Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Sexual Wellness
... CAGR of 4.7% over the analysis period 2024-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$47.0 Billion by the end of the analysis ... Read More
-
Sperm Banks
... CAGR of 5.3% over the analysis period 2024-2030. Sperm Storage, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Vaginal Odor Control Product
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.2 Billion by the ... Read More
-
Vitiligo Therapeutics
... CAGR of 4.0% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.2 Billion by the end of the analysis period. ... Read More
-
Psychiatric and Substance Abuse Hospitals
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.5 ... Read More
-
Artificial Limbs
... CAGR of 4.6% over the analysis period 2024-2030. Upper Extremity Prosthetics, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$925.8 Million by the end of the ... Read More
-
Bone Morphogenetic Proteins
... at a CAGR of 2.4% over the analysis period 2024-2030. Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$484.6 Million ... Read More
-
Cancer Cachexia
... CAGR of 5.7% over the analysis period 2024-2030. Progestogens, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Glaucoma Therapeutics
... CAGR of 3.5% over the analysis period 2024-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Hematological Malignancies
... CAGR of 6.2% over the analysis period 2024-2030. Leukemia, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$33.3 Billion by the end of the analysis period. ... Read More
-
Pigmentation Disorders Treatment
... at a CAGR of 5.7% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Spinal Fusion Devices
... at a CAGR of 3.4% over the analysis period 2024-2030. Thoracolumbar Devices, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Dental Bioimplants
... CAGR of 7.5% over the analysis period 2024-2030. Plate Form Dental Implant, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$15.0 Billion by the end of ... Read More
-
Immunotherapy Drugs
... CAGR of 9.6% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of the analysis ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Neuromodulation
... 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. ... Read More
-
Nocturia Drugs
... CAGR of 6.1% over the analysis period 2024-2030. Low Nocturnal Bladder Capacity, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Non-Melanoma Skin Cancer
... at a CAGR of 4.4% over the analysis period 2024-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 Million by the ... Read More
-
Nursing Breast Pads
... at a CAGR of 5.9% over the analysis period 2024-2030. Reusable, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 Million by the end of the ... Read More
-
Oncology Information Systems
... at a CAGR of 6.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Oncology Nutrition
... CAGR of 9.6% over the analysis period 2024-2030. Head & Neck, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$609.6 Million by the end of the ... Read More
Research Assistance
